PDEX - NASDAQ
Pro-Dex, Inc.
$65.17
-3.7%Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
At a Glance
Live SnapshotPro-Dex, Inc. Management Team
Mr. Richard Lee Van Kirk Jr.
Chief Executive Officer, President & Director
Compensation
$441,303
Ms. Alisha K. Charlton
Chief Financial Officer & Corporate Secretary
Compensation
$300,430
Mr. Chris Jackson
Directors of Operations
Pro-Dex, Inc. Insider Positioning
During the last 12 months, insiders have purchased $635 and sold $534K worth of PDEX shares, resulting in $533K of net selling activity.
3 Months
0
0.00
10.4K
533.71K
-534K
-$534K
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
15
635.00
0
0.00
+635
+$635
Top Buyers
Domingo Angelita Rebamontan
Director
$635
Top Sellers
Domingo Angelita Rebamontan
Director
$414K
Van Kirk Richard Lee Jr
Director, Officer: Chief Executive Officer
$119K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $533K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
2 insider sellers vs. 1 buyers. More insiders selling than buying suggests cautious or negative sentiment.
Insider Activity Insight
Persistent selling pressure: Consistent insider selling with weak buy/sell ratio suggests insiders may be capitalizing on current valuation. Exercise caution and review recent earnings quality and management commentary.
SEC Filings
PDEX - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | October 07, 2025 | November 20, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | October 08, 2024 | November 21, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | October 27, 2023 | December 14, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | October 03, 2022 | November 17, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | October 05, 2021 | November 18, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | October 06, 2020 | November 19, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | October 07, 2019 | November 21, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | October 05, 2018 | November 15, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | October 19, 2017 | December 05, 2017 | 2017 | |
DEF 14A DEF 14A 2016 N/A | October 17, 2016 | November 29, 2016 | 2016 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.